These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 21646575)

  • 21. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.
    Rylands AJ; Hinz R; Jones M; Holmes SE; Feldmann M; Brown G; McMahon AW; Talbot PS
    Biol Psychiatry; 2012 Dec; 72(12):1004-11. PubMed ID: 22835812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux.
    Sealover NR; Felts B; Kuntz CP; Jarrard RE; Hockerman GH; Lamb PW; Barker EL; Henry LK
    Biochem Pharmacol; 2016 Nov; 120():46-55. PubMed ID: 27638414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users.
    Semple DM; Ebmeier KP; Glabus MF; O'Carroll RE; Johnstone EC
    Br J Psychiatry; 1999 Jul; 175():63-9. PubMed ID: 10621770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[
    Tsai CJ; Chiu CH; Kuo YY; Huang WS; Yu TH; Flores LG; Yeh SH; Ma KH
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine.
    Ionescu TM; Amend M; Watabe T; Hatazawa J; Maurer A; Reischl G; Pichler BJ; Wehrl HF; Herfert K
    J Nucl Med; 2023 Mar; 64(3):466-471. PubMed ID: 36175138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia.
    Capela JP; Ruscher K; Lautenschlager M; Freyer D; Dirnagl U; Gaio AR; Bastos ML; Meisel A; Carvalho F
    Neuroscience; 2006; 139(3):1069-81. PubMed ID: 16504407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.
    Li IH; Ma KH; Kao TJ; Lin YY; Weng SJ; Yen TY; Chen LC; Huang YS
    Neurotoxicology; 2016 Jan; 52():114-26. PubMed ID: 26610922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?
    Buchert R; Thiele F; Thomasius R; Wilke F; Petersen K; Brenner W; Mester J; Spies L; Clausen M
    J Psychopharmacol; 2007 Aug; 21(6):628-34. PubMed ID: 17092972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.
    Buchert R; Thomasius R; Nebeling B; Petersen K; Obrocki J; Jenicke L; Wilke F; Wartberg L; Zapletalova P; Clausen M
    J Nucl Med; 2003 Mar; 44(3):375-84. PubMed ID: 12621003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.
    Klein AB; Trajkovska V; Erritzoe D; Haugbol S; Madsen J; Baaré W; Aznar S; Knudsen GM
    J Cereb Blood Flow Metab; 2010 Nov; 30(11):e1-7. PubMed ID: 20736957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
    Reneman L; Booij J; de Bruin K; Reitsma JB; de Wolff FA; Gunning WB; den Heeten GJ; van den Brink W
    Lancet; 2001 Dec; 358(9296):1864-9. PubMed ID: 11741626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.
    Gould RW; Gage HD; Banks ML; Blaylock BL; Czoty PW; Nader MA
    Neuropharmacology; 2011; 61(1-2):245-51. PubMed ID: 21521647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study.
    Kish SJ; Fitzmaurice PS; Chang LJ; Furukawa Y; Tong J
    J Psychopharmacol; 2010 Feb; 24(2):281-4. PubMed ID: 18832433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain.
    Reneman L; Endert E; de Bruin K; Lavalaye J; Feenstra MG; de Wolff FA; Booij J
    Neuropsychopharmacology; 2002 Mar; 26(3):387-96. PubMed ID: 11850153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.
    Callaghan PD; Farrand K; Salem A; Hughes P; Daws LC; Irvine RJ
    Eur J Pharmacol; 2006 Sep; 546(1-3):74-81. PubMed ID: 16925993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI.
    Schouw ML; Gevers S; Caan MW; Majoie CB; Booij J; Nederveen AJ; Reneman L
    Eur Neuropsychopharmacol; 2012 Aug; 22(8):537-45. PubMed ID: 22209360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.